Related content

The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients

By Chinwong Surarong   Reid Fiona   McGlynn Steve   Hudson Steve   Flapan Andy  

Pharmacy World and Science, Vol. 26, Iss. 2, 2004-04 ,pp. : 96-101

Springer Publishing Company

Access to resources Recommend Favorite

Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

By Maroo Bijesh P.   Lavie Carl J.   Milani Richard V.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 649-664

Adis International

Access to resources Recommend Favorite

Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction

By Thadani Udho   Ripley Toni L  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 385-396

Informa Healthcare

Access to resources Recommend Favorite

Potential of adenosine receptor agonists for the prevention and treatment of coronary artery disease and acute myocardial infarction

By Clark K.L.   Merkel L.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 1, 2000-02 ,pp. : 89-108

Informa Healthcare

Access to resources Recommend Favorite

Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort

By Haschke-Becher Elisabeth   Kirchheiner Julia   Trummer Olivia   Grünbacher Gerda   Kainz Alexander   Boehm Bernhard O   März Winfried   Renner Wilfried  

Pharmacogenomics, Vol. 11, Iss. 10, 2010-10 ,pp. : 1359-1365

Future Medicine

Access to resources Recommend Favorite